{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:06:33Z","timestamp":1775066793369,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Yunnan Provincial Department of Science and Technology and Kunming Medical University\u2019s Joint Special Funding for Applied Basic Research","award":["202101AY070001-250"],"award-info":[{"award-number":["202101AY070001-250"]}]},{"name":"The Yunnan Provincial Department of Science and Technology and Kunming Medical University\u2019s Joint Special Funding for Applied Basic Research","award":["202401AY070001-113"],"award-info":[{"award-number":["202401AY070001-113"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02690-1","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:08:39Z","timestamp":1741853319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrative analysis of serum proteomics and transcriptomics in hepatitis C"],"prefix":"10.1186","volume":"22","author":[{"given":"Jianqiong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yandi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Dao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"2690_CR1","unstructured":"Hepatitis C[EB\/OL]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"2690_CR2","unstructured":"Updated recommendations on treatment of adolescents and children. with chronic HCV infection, and HCV simplified service delivery and diagnostics[EB\/OL]. https:\/\/www.who.int\/publications\/i\/item\/9789240052734"},{"issue":"16","key":"2690_CR3","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3748\/wjg.v27.i16.1691","volume":"27","author":"D Castaneda","year":"2021","unstructured":"Castaneda D, Gonzalez AJ, Alomari M, et al. From hepatitis A to E: A critical review of viral hepatitis[J]. World J Gastroenterol. 2021;27(16):1691\u2013715.","journal-title":"World J Gastroenterol"},{"issue":"Suppl 3","key":"2690_CR4","first-page":"S344","volume":"17","author":"H Wedemeyer","year":"2002","unstructured":"Wedemeyer H, Wiegand J, Cornberg M, et al. Polyethylene glycol-interferon: current status in hepatitis C virus therapy[J]. J Gastroenterol Hepatol. 2002;17(Suppl 3):S344\u201350.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2690_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.apsb.2015.09.008","volume":"6","author":"X Zhang","year":"2016","unstructured":"Zhang X. Direct anti-HCV agents[J]. Acta Pharm Sin B. 2016;6(1):26\u201331.","journal-title":"Acta Pharm Sin B"},{"key":"2690_CR6","doi-asserted-by":"crossref","unstructured":"Di Marco L, La Mantia C, Di Marco V, Hepatitis C. Standard of treatment and what to do for global Elimination[J]. Viruses, 2022, 14(3).","DOI":"10.3390\/v14030505"},{"key":"2690_CR7","doi-asserted-by":"crossref","unstructured":"Fabrizi F, Tripodi F, Cerutti R et al. Recent information on Pan-Genotypic Direct-Acting antiviral agents for HCV in chronic kidney Disease[J]. Viruses, 2022, 14(11).","DOI":"10.3390\/v14112570"},{"issue":"4","key":"2690_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S2468-1253(23)00335-7","volume":"9","author":"AD Marshall","year":"2024","unstructured":"Marshall AD, Willing AR, Kairouz A, et al. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions[J]. Lancet Gastroenterol Hepatol. 2024;9(4):366\u201382.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"2690_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3350\/cmh.2024.0155","volume":"30","author":"CF Huang","year":"2024","unstructured":"Huang CF, Awad MH, Gal-Tanamy M, et al. Unmet needs in the post-direct-acting antivirals era: the risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication[J]. Clin Mol Hepatol. 2024;30(3):326\u201344.","journal-title":"Clin Mol Hepatol"},{"issue":"11","key":"2690_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jfma.2024.01.015","volume":"123","author":"S Maekawa","year":"2024","unstructured":"Maekawa S, Takano S, Enomoto N. Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment[J]. J Formos Med Assoc. 2024;123(11):1124\u201330.","journal-title":"J Formos Med Assoc"},{"key":"2690_CR11","doi-asserted-by":"publisher","first-page":"100568","DOI":"10.1016\/j.aohep.2021.100568","volume":"27","author":"C Celsa","year":"2022","unstructured":"Celsa C, Stornello C, Giuffrida P, et al. Direct-acting antiviral agents and risk of hepatocellular carcinoma: critical appraisal of the evidence[J]. Ann Hepatol. 2022;27:100568.","journal-title":"Ann Hepatol"},{"issue":"1","key":"2690_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13054-023-04364-2","volume":"27","author":"TM Pelaia","year":"2023","unstructured":"Pelaia TM, Shojaei M, Mclean AS. The role of transcriptomics in redefining critical Illness[J]. Crit Care. 2023;27(1):89.","journal-title":"Crit Care"},{"issue":"11","key":"2690_CR13","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/s41374-022-00830-7","volume":"102","author":"M Cui","year":"2022","unstructured":"Cui M, Cheng C, Zhang L. High-throughput proteomics: a methodological mini-review[J]. Lab Invest. 2022;102(11):1170\u201381.","journal-title":"Lab Invest"},{"issue":"11","key":"2690_CR14","doi-asserted-by":"publisher","first-page":"e1010968","DOI":"10.1371\/journal.ppat.1010968","volume":"18","author":"S Mazouz","year":"2022","unstructured":"Mazouz S, Salinas E, B\u00e9dard N, et al. Differential immune transcriptomic profiles between vaccinated and resolved HCV reinfected subjects[J]. PLoS Pathog. 2022;18(11):e1010968.","journal-title":"PLoS Pathog"},{"issue":"2","key":"2690_CR15","doi-asserted-by":"publisher","first-page":"e56153","DOI":"10.1371\/journal.pone.0056153","volume":"8","author":"V De Giorgi","year":"2013","unstructured":"De Giorgi V, Buonaguro L, Worschech A, et al. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis[J]. PLoS ONE. 2013;8(2):e56153.","journal-title":"PLoS ONE"},{"issue":"2","key":"2690_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00535-012-0661-5","volume":"48","author":"T Fukuhara","year":"2013","unstructured":"Fukuhara T, Matsuura Y. Role of miR-122 and lipid metabolism in HCV infection[J]. J Gastroenterol. 2013;48(2):169\u201376.","journal-title":"J Gastroenterol"},{"key":"2690_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.antiviral.2014.08.015","volume":"111","author":"MH Van Der Ree","year":"2014","unstructured":"Van Der Ree MH, Van Der Meer AJ, De Bruijne J, et al. Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients[J]. Antiviral Res. 2014;111:53\u20139.","journal-title":"Antiviral Res"},{"issue":"18","key":"2690_CR18","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","volume":"368","author":"HL Janssen","year":"2013","unstructured":"Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA[J]. N Engl J Med. 2013;368(18):1685\u201394.","journal-title":"N Engl J Med"},{"issue":"9","key":"2690_CR19","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1073\/pnas.1518934113","volume":"113","author":"M Lussignol","year":"2016","unstructured":"Lussignol M, Kopp M, Molloy K, et al. Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis[J]. Proc Natl Acad Sci U S A. 2016;113(9):2484\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2690_CR20","doi-asserted-by":"publisher","first-page":"e0147991","DOI":"10.1371\/journal.pone.0147991","volume":"11","author":"S Liu","year":"2016","unstructured":"Liu S, Zhao T, Song B, et al. Comparative proteomics reveals important Viral-Host interactions in HCV-Infected human liver Cells[J]. PLoS ONE. 2016;11(1):e0147991.","journal-title":"PLoS ONE"},{"issue":"5","key":"2690_CR21","doi-asserted-by":"publisher","first-page":"e0177352","DOI":"10.1371\/journal.pone.0177352","volume":"12","author":"V Cento","year":"2017","unstructured":"Cento V, Nguyen THT, Di Carlo D, et al. Improvement of ALT decay kinetics by all-oral HCV treatment: role of NS5A inhibitors and differences with IFN-based regimens[J]. PLoS ONE. 2017;12(5):e0177352.","journal-title":"PLoS ONE"},{"issue":"10","key":"2690_CR22","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1128\/AAC.00910-13","volume":"57","author":"DA Wilfret","year":"2013","unstructured":"Wilfret DA, Walker J, Adkison KK, et al. Safety, tolerability, pharmacokinetics, and antiviral activity of GSK2336805, an inhibitor of hepatitis C virus (HCV) NS5A, in healthy subjects and subjects chronically infected with HCV genotype 1[J]. Antimicrob Agents Chemother. 2013;57(10):5037\u201344.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2690_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11883-022-01078-8","volume":"25","author":"P Mohammadi-Shemirani","year":"2023","unstructured":"Mohammadi-Shemirani P, Sood T, Par\u00e9 G. From \u2018omics to Multi-omics technologies: the discovery of novel causal Mediators[J]. Curr Atheroscler Rep. 2023;25(2):55\u201365.","journal-title":"Curr Atheroscler Rep"},{"key":"2690_CR24","doi-asserted-by":"crossref","unstructured":"Selvarajoo K, Maurer-Stroh S. Towards multi-omics synthetic data integration[J]. Brief Bioinform, 2024, 25(3).","DOI":"10.1093\/bib\/bbae213"},{"key":"2690_CR25","unstructured":"Zhi CM, a J Z G Z B. Z. Guidelines for the prevention and treatment of hepatitis C (2019 version)[J], 2019, 27: 962\u2013\u200979."},{"issue":"06","key":"2690_CR26","first-page":"428","volume":"15","author":"CMA Diseases","year":"2022","unstructured":"Chinese Society of Hepatology C M A, Chinese Society of Infectious, Diseases CMA, Wei L, et al. Guideline for the prevention and treatment of hepatitis C (2022 version)[J]. Chin J Clin Infect Dis. 2022;15(06):428\u201347.","journal-title":"Chin J Clin Infect Dis"},{"issue":"12","key":"2690_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2[J]. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"43","key":"2690_CR28","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles[J]. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2690_CR29","unstructured":"Aleksander SA, Balhoff J, Carbon S et al. The gene ontology knowledgebase in 2023[J]. Genetics, 2023, 224(1)."},{"issue":"1","key":"2690_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes[J]. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"2690_CR31","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","volume":"28","author":"L Wang","year":"2012","unstructured":"Wang L, Wang S, Li W. RSeQC: quality control of RNA-seq experiments[J]. Bioinformatics. 2012;28(16):2184\u20135.","journal-title":"Bioinformatics"},{"issue":"17","key":"2690_CR32","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, et al. Fastp: an ultra-fast all-in-one FASTQ preprocessor[J]. Bioinformatics. 2018;34(17):i884\u201390.","journal-title":"Bioinformatics"},{"issue":"4","key":"2690_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements[J]. Nat Methods. 2015;12(4):357\u201360.","journal-title":"Nat Methods"},{"issue":"7","key":"2690_CR34","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features[J]. Bioinformatics. 2014;30(7):923\u201330.","journal-title":"Bioinformatics"},{"issue":"4","key":"2690_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method[J]. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"4","key":"2690_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00705-023-05743-4","volume":"168","author":"C Zou","year":"2023","unstructured":"Zou C, Tan H, Zeng J, et al. Hepatitis C virus nonstructural protein 4B induces lipogenesis via the Hippo pathway[J]. Arch Virol. 2023;168(4):113.","journal-title":"Arch Virol"},{"issue":"1","key":"2690_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1139\/o06-195","volume":"85","author":"N Majeau","year":"2007","unstructured":"Majeau N, Bolduc M, Duvignaud JB, et al. Effect of cAMP-dependent protein kinase A (PKA) on HCV nucleocapsid assembly and degradation[J]. Biochem Cell Biol. 2007;85(1):78\u201387.","journal-title":"Biochem Cell Biol"},{"issue":"10","key":"2690_CR38","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1515\/BC.2009.118","volume":"390","author":"JG Bode","year":"2009","unstructured":"Bode JG, Brennd\u00f6rfer ED, Karthe J, et al. Interplay between host cell and hepatitis C virus in regulating viral replication[J]. Biol Chem. 2009;390(10):1013\u201332.","journal-title":"Biol Chem"},{"issue":"3","key":"2690_CR39","first-page":"2517","volume":"16","author":"J Yang","year":"2024","unstructured":"Yang J, Wu X, You J. Unveiling the potential of HSPA4: a comprehensive pan-cancer analysis of HSPA4 in diagnosis, prognosis, and immunotherapy[J]. Aging. 2024;16(3):2517\u201341.","journal-title":"Aging"},{"key":"2690_CR40","doi-asserted-by":"crossref","unstructured":"Lubkowska A, Pluta W, Stro\u0144ska A et al. Role of heat shock proteins (HSP70 and HSP90) in viral Infection[J]. Int J Mol Sci, 2021, 22(17).","DOI":"10.3390\/ijms22179366"},{"issue":"4","key":"2690_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ijantimicag.2016.01.012","volume":"47","author":"R Khachatoorian","year":"2016","unstructured":"Khachatoorian R, Riahi R, Ganapathy E, et al. Allosteric heat shock protein 70 inhibitors block hepatitis C virus assembly[J]. Int J Antimicrob Agents. 2016;47(4):289\u201396.","journal-title":"Int J Antimicrob Agents"},{"key":"2690_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clinbiochem.2018.12.001","volume":"63","author":"EA Toraih","year":"2019","unstructured":"Toraih EA, Alrefai HG, Hussein MH, et al. Overexpression of heat shock protein HSP90AA1 and translocase of the outer mitochondrial membrane TOM34 in HCV-induced hepatocellular carcinoma: A pilot study[J]. Clin Biochem. 2019;63:10\u20137.","journal-title":"Clin Biochem"},{"issue":"7","key":"2690_CR43","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10147-021-01933-9","volume":"26","author":"C Yuan","year":"2021","unstructured":"Yuan C, Wang D, Liu G, et al. Jab1\/Cops5: a promising target for cancer diagnosis and therapy[J]. Int J Clin Oncol. 2021;26(7):1159\u201369.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"2690_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s10020-023-00675-w","volume":"29","author":"Y Yang","year":"2023","unstructured":"Yang Y, Song R, Gao Y, et al. Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders[J]. Mol Med. 2023;29(1):80.","journal-title":"Mol Med"},{"issue":"13","key":"2690_CR45","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1158\/1078-0432.CCR-07-5040","volume":"14","author":"MC Hsu","year":"2008","unstructured":"Hsu MC, Huang CC, Chang HC, et al. Overexpression of Jab1 in hepatocellular carcinoma and its Inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo[J]. Clin Cancer Res. 2008;14(13):4045\u201352.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2690_CR46","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/hep.23697","volume":"52","author":"K Machida","year":"2010","unstructured":"Machida K, Tsukamoto H, Liu JC, et al. c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair[J]. Hepatology. 2010;52(2):480\u201392.","journal-title":"Hepatology"},{"issue":"2","key":"2690_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/embo-reports\/kve028","volume":"2","author":"DA Chamovitz","year":"2001","unstructured":"Chamovitz DA, Segal D. JAB1\/CSN5 and the COP9 signalosome. A complex situation[J]. EMBO Rep. 2001;2(2):96\u2013101.","journal-title":"EMBO Rep"},{"issue":"19","key":"2690_CR48","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1042\/BCJ20170378","volume":"475","author":"KR Willison","year":"2018","unstructured":"Willison KR. The structure and evolution of eukaryotic chaperonin-containing TCP-1 and its mechanism that folds actin into a protein spring[J]. Biochem J. 2018;475(19):3009\u201334.","journal-title":"Biochem J"},{"key":"2690_CR49","doi-asserted-by":"publisher","first-page":"906530","DOI":"10.3389\/fcell.2022.906530","volume":"10","author":"H Ghozlan","year":"2022","unstructured":"Ghozlan H, Cox A, Nierenberg D, et al. The tricky business of protein folding in health and Disease[J]. Front Cell Dev Biol. 2022;10:906530.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2690_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.virol.2010.10.026","volume":"410","author":"Y Inoue","year":"2011","unstructured":"Inoue Y, Aizaki H, Hara H, et al. Chaperonin TRiC\/CCT participates in replication of hepatitis C virus genome via interaction with the viral NS5B protein[J]. Virology. 2011;410(1):38\u201347.","journal-title":"Virology"},{"issue":"16","key":"2690_CR51","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/bdr2.2007","volume":"114","author":"I Patel","year":"2022","unstructured":"Patel I, Parchem RJ. Regulation of Oct4 in stem cells and neural crest cells[J]. Birth Defects Res. 2022;114(16):983\u20131002.","journal-title":"Birth Defects Res"},{"issue":"4","key":"2690_CR52","doi-asserted-by":"publisher","first-page":"165432","DOI":"10.1016\/j.bbadis.2019.03.005","volume":"1866","author":"IS Mohiuddin","year":"2020","unstructured":"Mohiuddin IS, Wei SJ, Kang MH. Role of OCT4 in cancer stem-like cells and chemotherapy resistance[J]. Biochim Biophys Acta Mol Basis Dis. 2020;1866(4):165432.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"2690_CR53","doi-asserted-by":"publisher","first-page":"672","DOI":"10.4049\/jimmunol.2001453","volume":"208","author":"W Li","year":"2022","unstructured":"Li W, Duan X, Zhu C, et al. Hepatitis B and hepatitis C virus infection promote liver fibrogenesis through a TGF-\u03b21-Induced OCT4\/Nanog Pathway[J]. J Immunol. 2022;208(3):672\u201384.","journal-title":"J Immunol"},{"issue":"1","key":"2690_CR54","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3892\/or.2016.4775","volume":"36","author":"JJ Zhou","year":"2016","unstructured":"Zhou JJ, Meng Z, Zhou Y, et al. Hepatitis C virus core protein regulates OCT4 expression and promotes cell cycle progression in hepatocellular carcinoma[J]. Oncol Rep. 2016;36(1):582\u20138.","journal-title":"Oncol Rep"},{"issue":"1","key":"2690_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1006\/geno.1997.5053","volume":"47","author":"T Eki","year":"1998","unstructured":"Eki T, Okumura K, Abe M, et al. Mapping of the human genes encoding Cyclin H (CCNH) and the CDK-activating kinase (CAK) assembly factor MAT1 (MNAT1) to chromosome bands 5q13.3-q14 and 14q23, respectively[J]. Genomics. 1998;47(1):115\u201320.","journal-title":"Genomics"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02690-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02690-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02690-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:40:00Z","timestamp":1741855200000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02690-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2690"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02690-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the First People\u2019s Hospital of Yunnan Province and the subjects approved this study (Approval No. 2020KYS112), and the subjects signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All subjects consented to the publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}